TOH-2021-055 - FLOW CYTOMETER

The Ottawa Hospital (TOH) is seeking proposals for the provision of a flow cytometer
instrument, including 4 years of post-warranty service.
In support of the development, testing and validation of quality control assays and
cellular therapies at the Ottawa Hospital Research Institute, we wish to expand the
capabilities of the Biotherapeutics Manufacturing Center – Cell Manufacturing Facility for
the identification and enumeration of cell populations.
A flow cytometer instrument will detect, identify, and enumerate cell populations in
different types of samples, blood, bone marrow, cell culture, etc. The ability to
differentiate cell populations is crucial for the development and characterization of safe
and efficacious cellular therapy products.
This instrument will have a critical impact on the Quality Assurance program at the CMF
and the safety and efficacy of research products for the treatment of Pulmonary Arterial
Hypertension, COVID-19 and bronchopulmonary dysplasia.